SelectQuote (SLQT) Q4 2026 Earnings Call Transcript
SelectQuote reported fiscal 2026 revenue of $1.6B, up 6% YoY, with adjusted EBITDA of $109.1M. Healthcare Services revenue grew 14% to $845M. Fiscal 2027 guidance includes revenue of $1.35B-$1.45B and adjusted EBITDA of $90M-$115M. Management highlighted cash flow improvement and debt reduction strategies, noting industry volatility in Medicare Advantage.
How this was made

The 30-second read
Why it matters
The company delivered a modest profit improvement and raised cash flow expectations, signaling operational discipline.
Market read
First release of SelectQuote's FY2026 earnings and FY2027 guidance, providing actionable data for traders.
What to watch
Potential regulatory changes to Medicare Advantage and drug pricing could affect future performance.
Background
SelectQuote (SLQT) held its FY2026 earnings call, presenting results and FY2027 outlook.
Ticker impact
SelectQuote reported FY2026 revenue of $1.6B and issued FY2027 revenue guidance of $1.35‑$1.45B, plus adjusted EBITDA and cash flow guidance.
Potential upside of 5‑10% on the day of release, with volatility on guidance details.
First disclosure of full-year results and forward guidance provides fresh material for pricing.
Market effects
Healthcare services and Medicare Advantage segments may see broader sentiment shifts.
U.S. insurance and health‑care stocks could react to SelectQuote's guidance.
Limited; primarily U.S. market impact.
Counterpoint
If guidance falls short of consensus expectations, the stock could face a sharp sell‑off.
Key entities
- ExecutiveTimothy Danker
CEO of SelectQuote
- ExecutiveRyan Clement
CFO of SelectQuote



